Second-Half Slump Pulls Genomics Stocks Down Sharply in 2011 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A strong first half of the year for the GenomeWeb Daily News Index eroded over the back half of 2011 as the stock prices of many genomics tools and some molecular diagnostics vendors fell amid challenging market conditions.

Driving the slide in the genomics tools sector has been uncertainty surrounding public funding sources for research and a slowdown among some customer end markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.